NCT02045979 - Pharmacokinetics and Safety in Healthy Volunteers | Biotech Hunter

Enrollment

327

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 20, 2014

Study Completion Date

June 20, 2014

Conditions

Healthy

Interventions

DRUG

BI 695501

BI 695501 single s.c. injection

DRUG

adalimumab-EU source

adalimumab-EU source single s.c. injection

DRUG

adalimumab-US source

adalimumab-US source single s.c. injection.

Trial Locations (3)

1297.8.1001 Boehringer Ingelheim Investigational Site, Antwerp

1297.8.2001 Boehringer Ingelheim Investigational Site, Auckland

1297.8.2002 Boehringer Ingelheim Investigational Site, Christchurch